Search

Search Constraints

You searched for: Author/Creator Gasbarrini, A.

Search Results

51. OC.01.4 SAFETY AND EFFICACY OF EUS-GUIDED RADIOFREQUENCY ABLATION FOR PANCREATIC INSULINOMA: A SINGLE-CENTRE EXPERIENCE. (March 2023)

53. OC.02.5 EFFECTIVENESS, SAFETY AND IMMUNOGENICITY OF SWITCHING FROM ORIGINATOR INFILIXIMAB TO BIOSIMILAR INFLIXIMAB (CT-P13) IN A LARGE COHORT OF IBD PATIENTS. (1st October 2020)

54. OC.02.5 THE SOLUTE CARRIER LC22A4/OCTN1 AS A NOVEL IBD DETERMINANT AT THE MICROBE-HOST INTERFACE. (May 2022)

55. OC.03.4 DECREASE OF BLOODSTREAM INFECTION RATES IN PATIENTS WITH CLOSTRIDIUM DIFFICILE INFECTION TREATED WITH FAECAL MICROBIOTA TRANSPLANTATION: A PROSPECTIVE OBSERVATIONAL COHORT STUDY. (25th March 2019)

58. OC.04.3 REAL-LIFE VS TRIAL ACCESS TO BIOLOGIC THERAPY DIFFERENCES: A 2019-2020 EXPERIENCE IN AN ITALIAN TERTIARY IBD CENTER. (March 2023)

59. OC.04.5 IL-33/ST2 LEVELS AND GUT MICROBIOTA CHARACTERIZATION CAN PREDICT MUCOSAL RESPONSE TO ANTI-TNF THERAPY IN ULCERATIVE COLITIS. (25th March 2019)

60. OC.05.1: EUS-Guided Tissue Acquisition with 20-Gauge Procore Needle and "Wet" Technique 19-Gauge Flex FNA in Solid Pancreatic and Non-Pancreatic Masses – A Single Centre Experience. (15th March 2017)